Terms: = Liver cancer AND RPL5, 6125, P46777, MSTP030, MGC117339, ENSG00000122406 AND Treatment
3 results:
1. Exploring the molecular mechanism of hepatitis virus inducing hepatocellular carcinoma by microarray data and immune infiltrates analysis.
Zhang YZ; Zeb A; Cheng LF
Front Immunol; 2022; 13():1032819. PubMed ID: 36439183
[TBL] [Abstract] [Full Text] [Related]
2. Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis.
Saeki C; Matsuzaki J; Kuroda M; Fujita K; Ichikawa M; Takizawa S; Takano K; Oikawa T; Nakanuma Y; Saruta M; Ochiya T; Tsubota A
BMJ Open Gastroenterol; 2022 Apr; 9(1):. PubMed ID: 35379653
[TBL] [Abstract] [Full Text] [Related]
3. Targeted Proteomics Predicts a Sustained Complete-Response after Transarterial Chemoembolization and Clinical Outcomes in Patients with Hepatocellular Carcinoma: A Prospective Cohort Study.
Yu SJ; Kim H; Min H; Sohn A; Cho YY; Yoo JJ; Lee DH; Cho EJ; Lee JH; Gim J; Park T; Kim YJ; Kim CY; Yoon JH; Kim Y
J Proteome Res; 2017 Mar; 16(3):1239-1248. PubMed ID: 28112944
[TBL] [Abstract] [Full Text] [Related]